niadenate has been researched along with tetradecanoylphorbol acetate in 2 studies
| Studies (niadenate) | Trials (niadenate) | Recent Studies (post-2010) (niadenate) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikalsen, SO; Rivedal, E; Sanner, T | 1 |
| Aarsaether, N; Berge, RK; Lillehaug, JR; Male, R | 1 |
2 other study(ies) available for niadenate and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.
Topics: 2,4-Dichlorophenoxyacetic Acid; 2,4,5-Trichlorophenoxyacetic Acid; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Clofibrate; Cricetinae; Diethylhexyl Phthalate; Digitonin; Embryo, Mammalian; Fatty Alcohols; Hypolipidemic Agents; Liver; Mesocricetus; Microbodies; Nicotinic Acids; Rats; Tetradecanoylphorbol Acetate | 1991 |
Peroxisome proliferators show tumor-promoting but no direct transforming activity in vitro.
Topics: Adipose Tissue; Animals; Carcinogens; Cell Division; Cell Transformation, Neoplastic; Clofibrate; Dose-Response Relationship, Drug; Fatty Alcohols; Hypolipidemic Agents; Mice; Microbodies; Nicotinic Acids; Tetradecanoylphorbol Acetate | 1986 |